November 9-11, 2008
Centers for Disease Control and Prevention
Atlanta, Georgia, USA

About BioFusion | Register | Program | Presenters | Sponsors | Venue & Lodging | BioSouth

 

BioFusion 2008 Program will be posted soon.


 

2006 Program

BioFusion 2006 Conference Agenda
click here

Highlights from the 2006 conference:

Technology Presentations
Companies, universities and research institutions from across the globe presented cutting edge technologies available for partnering and licensing.

Technology Showcase Open House
Senior executives, scientists and business development representatives for emerging and established bioscience technologies reached the BioFusion audience in this interactive pavilion environment.

Technology Seekers
Large pharma, medical device and biotechnology leaders spoke to the audience about the types of technologies they are seeking and discussed their methodologies for partnering and licensing. Participants: Merck, GlaxoSmithKline, Solvay, 3M, Eli Lilly, Pfizer and Genzyme.

Partnering Meetings
One-to-one meetings allowed for further partnering discussions and were arranged prior to the conference through biopartnering.com or on-site with the help of our meetings staff. A unique and powerful internet tool, biopartnering.com, allows a proactive user to prepare for private meetings with potential partners before attending a conference. You are able to access the password protected area of the site to research partnering opportunities through keyword searches of detailed profiles on all companies, contact other users, arrange private meetings and reserve meeting space at an event.

Login to biopartnering.com
For registered conference attendees only.

Golf Tournament & Networking
BioFusion colleagues gathered for networking and fun at the Duke University Golf Club for the first annual BioFusion Golf Tournament on Sunday, September 17th. That evening, we welcomed all of our guests at the Washington Duke's Terrace on the Green for our opening cocktail reception. Monday evening featured a dinner reception in the Durham community that was another great networking opportunity.


Preliminary Conference Agenda
(subject to change)

Sunday, September 17th
9:00 - 2:00

BioFusion Golf Tournament
Duke University Golf Club @ Washington Duke

4:00 - 5:00

Registration
Conference Area

5:00 - 6:00

Welcome Cocktail Reception
Sponsored by Square 1 Bank & Canadian Consulate General

Welcome by Dr. Kenneth Tindall- Senior Vice President for Science and Business Development, North Carolina Biotechnology Center
Terrace on the Green

6:00 - 7:00

 

Monday, September 18th
7:30 - 8:30
Registration
Conference Area
&
Continental Breakfast
Sponsored by MedTRACK
Presidents Gallery
8:30 - 9:30

General Session
Presidents I & II

Welcome by Dr. Robert K. McMahan - Senior Advisor to the Governor for Science and Technology and Executive Director, NC Board of Science and Technology
&
Keynote Presentation by Richard N. Kender - Vice President, Business Development & Corporate Licensing - Merck & Co., Inc.

 
Technology Presentations
Forest

Technology Showcase & Networking Lounge
Presidents III & IV

9:30AM to 12:30PM

One-To-One Partnering Meetings
Ambassador Duke

9:30AM - 12:30PM

Meetings may be requested via biopartnering.com or on-site at the Meetings Desk

Private and semi-private meeting rooms are available in 30 minute or 1 hour blocks.

9:30 - 9:50
Syntherica - North Carolina

Synthetide(tm) Synthetic Antibodies

Warwick Effect Polymers - UK



Aetos Technologies - Alabama



Code Refinery - North Carolina



Cardinal Health - North Carolina



CleveMed - Ohio



Agenta Biotechnologies - Alabama


Copernicus Group IRB - North Carolina

9:50 - 10:10
Collexis - South Carolina

Major Advancement in Knowledge Discovery
10:10 - 10:30
Precision BioSciences - North Carolina

Enabling Targeted Genomic Manipulations
10:30 - 10:50
TransPharma Medical - Israel

The ViaDerm System: A Transdermal System for Delivery of Therapuetical Compounds
10:50 - 11:10

Metastatix - Georgia

No
vel HIV Entry Inhibitor

11:10 - 11:30

Avatar BioSci - Tennessee

Identification and Validation of Host Genes Required for Viral Pathogenesis

11:30 - 11:50
Cardinal Health - North Carolina

GPExTM: Gene Insertion Technology for the Rapid Development of Stable, High-Expressing Mammalian Cell Lines
11:50 - 12:10

Abeome - Georgia

Platform for Rapid Selection of Hybridomas

12:10 - 12:30

TBD

12:30 - 2:00

Lunch Presentation & Panel
Presidents I & II


Bioscience Developments & Partnering Opportunities in the Southern U.S.
Sponsored by Thompson Hine LLP

Moderator: Frank McDaniel - Thompson Hine, LLP; Chair - BioSouth, Inc.

Panelists:
Dr. Harry Orf - Vice President for Scientific Operations and Professor of Chemistry, Scripps Research Institute - Scripps Florida
Clyde Higgs - Vice President for Business Development, Castle & Cooke North Carolina; North Carolina Research Campus

  Technology Presentations
Forest

Regional Presentations
Ambassador Allen

One-To-One Partnering Meetings
Ambassador Duke

2:00PM - 5:00PM

Meetings may be requested via biopartnering.com or on-site at the Meetings Desk

Private and semi-private meeting rooms are available in 30 minute or 1 hour blocks.

2:00 - 2:20

TM BioScience - Canada

Development and Commercialization of BioMarkers and Disease Panels

Opportunities in North Carolina's Growing Bioscience Industry

Monica P. Doss - President and CEO, Council for Entrepreneurial Development

John Richert - Vice President, Business & Technology Development, North Carolina
Biotechnology Center

Sam Taylor - President, North Carolina Biosciences Organization

2:20 - 2:40 Stem Cell Innovations - Texas

Human Pluripotent Stem Cells for Use in Drug Discovery and Cell Therapy
2:40 - 3:00

Cognosci - North Carolina

Novel Therapeutics for Multiple Sclerosis

3:00 - 3:20 ImmunoBiosciences - North Carolina

Immune Complex Vaccine Technology

Bioscience Partnering Opportunities in Canada

Dr. Colleen Christensen - Lifesciences Industrial Liaison Scientist, Canadian Light Source Inc.

Scott Ferguson - Business Relations, National Research Council of Canada - Institute for Biological Sciences

3:20 - 3:40 WYNDEN Pharmaceuticals - Georgia

Therapeutics for Electrolyte Repletion
3:40 - 4:00

Liquidia Technologies - North Carolina

PRINT Particles and the Treatment of Human Disease

4:00 - 5:00

Panel: Getting Products from Clinic to the Market
(Without necessarily relying on a big pharma partnership)
Presidents I & II

Moderator: Bill Wofford - Life Sciences Practice Group Leader, Hutchison Law Group

Panelists:
Jeff Abbey - Vice President of Business Development, Argos Therapeutics
Ben Bonifant - Vice President, Campbell Alliance
David Pierson - Partner, Intersouth Partners
Susan Lillard Thomason - Executive Director, Global Business Development, NovaQuest

5:00 - 7:30 BioFusion Dinner Reception
Sponsored by Duke University

Welcome by MaryAnn Black - Associate Vice President for Community Affairs,
Duke University Health System
Presidents Terrace

 

Tuesday, September 19th
7:30 - 8:30
Registration
Conference Area
&
Continental Breakfast
Sponsored by MedTRACK
Presidents Gallery
8:30 - 9:30

General Session
Presidents I & II

Welcome & Panel: Changes in Global Partnering for the Bioscience Industry

Moderator - Dr. Abel De La Rosa - Senior Vice President for Business Development & Scientific Affairs, Pharmasset
Dr. Nancy Shepherd - Director, Technology Licensing, Worldwide Business Development, GlaxoSmithKline
Dr. Michael A. Recny - Vice President of Corporate Development, Trimeris, Inc.
Dr. Roman Szumski - Vice President of Life Sciences, National Research Council Canada

 
Technology Seekers' Presentations
Presidents I & II

One-To-One Partnering Meetings
Ambassador Duke

9:30AM - 4:30PM

Meetings may be requested via biopartnering.com or on-site at the Meetings Desk

Private and semi-private meeting rooms are available in 30 minute or 1 hour blocks.

9:30 - 9:50
Merck & Co. Inc.
Pamela Demain - Executive Director, Corporate Licensing
9:50 - 10:10
3M Health Care
Susan Paquette - Commercialization Director
10:10 - 10:30
Solvay Pharmaceuticals
Dr. Joseph C. Nolan - Director, Business Development
10:30 - 10:50
GlaxoSmithKline
Gregg Davis - Director, Worldwide Business Development
10:50 - 11:10
Genzyme
Dr. Bruce M. Pratt - Vice President, Science Development
11:10 - 11:30
Eli Lilly & Company
Mark A. Miller - Senior Director, Corporate Business Development
11:30 - 11:50
Pfizer
Dr. Mary L. Mayer - Associate Director, Strategic Alliances
11:50 - 12:10
TBD
12:10 - 1:30
Buffet Lunch Available
Presidents Gallery

BioFusion Workshop
(Registration Required)

Going Global - Considerations For Conducting International Clinical Trials
Ambassador Allen

Penny Smith, Esq. - Thompson Hine, LLP

Marc Ingham, Esq. - Manager, Legal Agreements, Duke Clinical Research Institute

Mary Ann Sellers - MSN Operations Manager, Duke Clinical Research Institute

BioFusion Workshop
(Registration Required)

Opportunities in the
Canadian and U.S. Neutraceuticals/Neutriscience Industries
Forest

Moderator: Dr. A. Elizabeth Robinson - Trade Commissioner, Canadian Consulate--RALDM

Dr. Michael Mayne - Director of Research, National Research Council Canada (NRC) Institute for Nutrisciences and Health

Clyde Higgs - Vice President, Business Development, North Carolina Research Campus

Dr. Roman Szumski - VP Life Sciences, National Research Council Canada

1:30 - 4:30


produced by
BioSouth, Inc.